CSL Biotherapies, a subsidiary of CSL Limited, received licensure from the FDA for its newest vaccine filling and packaging facility in Kankakee, IL. The facility is part of an investment to expand CSL’s U.S. influenza vaccine production capabilities and includes a high-speed, single-dose vaccine syringe filling line. The company also recently signed an initial contract for at least $180 million to supply the U.S. Department of Health & Human Services (HHS) with Novel Influenza A (H1N1) anti...